USE OF NEBIVOLOL AS AN ANTI-ATHEROGENIC

This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous...

Full description

Saved in:
Bibliographic Details
Main Authors DE CHAFFOY DE COURCELLES, DIDIER ROBERT GUY GABRIEL, LESAGE, ANNE SIMONE JOSEPHINE, LEYSEN, JOSEPHA EDUARDA MARIA FRANCISCA
Format Patent
LanguageEnglish
French
Published 17.10.2006
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stres s.
AbstractList This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the therapeutic or prophylactic treatment of humans suffering from or prone to degenerative diseases and conditions of the vascular and nervous system which are associated with oxidative stres s.
Author DE CHAFFOY DE COURCELLES, DIDIER ROBERT GUY GABRIEL
LESAGE, ANNE SIMONE JOSEPHINE
LEYSEN, JOSEPHA EDUARDA MARIA FRANCISCA
Author_xml – fullname: DE CHAFFOY DE COURCELLES, DIDIER ROBERT GUY GABRIEL
– fullname: LESAGE, ANNE SIMONE JOSEPHINE
– fullname: LEYSEN, JOSEPHA EDUARDA MARIA FRANCISCA
BookMark eNrjYmDJy89L5WRQDw12VfB3U_BzdfIM8_fx91FwDFZw9AOiEE9dxxAP1yB_d1c_T2ceBta0xJziVF4ozc0g7-Ya4uyhm1qQH59aXJCYnJqXWhLv7GhkZGBubGzsbExYBQAXLSRL
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate UTILISATION DE NEBIVOLOL COMME AGENT ANTI-ATHEROGENE
ExternalDocumentID CA2207333C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2207333C3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:56:24 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2207333C3
Notes Application Number: CA19952207333
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061017&DB=EPODOC&CC=CA&NR=2207333C
ParticipantIDs epo_espacenet_CA2207333C
PublicationCentury 2000
PublicationDate 20061017
PublicationDateYYYYMMDD 2006-10-17
PublicationDate_xml – month: 10
  year: 2006
  text: 20061017
  day: 17
PublicationDecade 2000
PublicationYear 2006
RelatedCompanies JANSSEN PHARMACEUTICA, NAAMLOZE VENNOOTSCHAP
RelatedCompanies_xml – name: JANSSEN PHARMACEUTICA, NAAMLOZE VENNOOTSCHAP
Score 2.6618097
Snippet This invention relates to the use of an .alpha.,.alpha.'- iminobis(methylene)bis[2-chromanmethanol] derivative for the manufacture of a medicament for the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title USE OF NEBIVOLOL AS AN ANTI-ATHEROGENIC
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20061017&DB=EPODOC&locale=&CC=CA&NR=2207333C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dS8MwED_mFPVNpzK_-yD1qYhN2s6HIm2a2spsxtaNvY007dCXOVzFf98krNOXQR5CApcP7nK5y90vAHeO5xVoPkeWh0ph4fIRWdzuqdSngkuecQTmOkA2c5Mxfp060xa8N7kwGif0R4MjSokSUt5rfV4v_5xYkY6tXD0UH7Lp8znO_cjcWMeKw8wo9OmARYyYhPgkMLOhb9vqd0JEdmBXXaIVyj6dhConZflfocRHsDeQtBb1MbSqRQcOSPPvWgf239bP3bK6lrzVCdyPR9RgsZHRMJ2wPusbwcgIMlny1AryhA7ZC81Scgq3Mc1JYskRZ5vFzUjQTA2dQVua_FUXDK5Q-aRpVmHMMRe85xWuh59KhRYjkCvOobuNysX2rks41A4EFY_hXUG7_vqurqVKrYsbvRu_4MB1tw
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3dT8IwEL8gGvFNUYOf7MHMp8W4FooPixld56ZjIzAIb0vXjegLEpnx37dtAH0h6UPTJteP3PVy17vfAdx1CMnRfI4sggph4eIRWdzuqdSnnEue6QjMdYBs3A0m-HXWmdXgfZMLo3FCfzQ4opQoIeW90u_18s-J5enYytVD_iGHPp_91PHMrXWsOMz0-g4bJl5CTUod6prxyLFtVZ0Q0T3YJ9IgVCj7bNpXOSnL_wrFP4aDoaS1qE6gVi6a0KCbumtNOBysv7tldy15q1O4n4yZkfhGzPrhNImSyHDHhhvLloaWmwZslLywOKRn0PZZSgNLrphtD5dRd7M1dA51afKXLTC4QuWTplmJMcdc8B7JuwQ_FQotRqCuuIDWLiqXu6fa0AjSQZRFYfx2BUfamaBiM8g11Kuv7_JGqtcqv9U38wuHn3ii
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+NEBIVOLOL+AS+AN+ANTI-ATHEROGENIC&rft.inventor=DE+CHAFFOY+DE+COURCELLES%2C+DIDIER+ROBERT+GUY+GABRIEL&rft.inventor=LESAGE%2C+ANNE+SIMONE+JOSEPHINE&rft.inventor=LEYSEN%2C+JOSEPHA+EDUARDA+MARIA+FRANCISCA&rft.date=2006-10-17&rft.externalDBID=C&rft.externalDocID=CA2207333C